ExodusPoint Capital Management’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-68,000
Closed -$220K 1842
2024
Q3
$220K Buy
+68,000
New +$220K ﹤0.01% 1323
2022
Q4
Sell
-29,786
Closed -$1.1M 1990
2022
Q3
$1.1M Buy
29,786
+11,531
+63% +$427K 0.01% 1039
2022
Q2
$347K Buy
+18,255
New +$347K ﹤0.01% 1436
2020
Q2
Sell
-28,252
Closed -$964K 1948
2020
Q1
$964K Buy
28,252
+16,497
+140% +$563K 0.05% 278
2019
Q4
$458K Buy
+11,755
New +$458K 0.01% 850